Alcon Inc. (SWX:ALC)
Switzerland · Delayed Price · Currency is CHF 54.44
+0.40 (0.74%)
Jul 10, 2026, 5:30 PM CET
Alcon Revenue
Alcon had revenue of $2.71B USD in the quarter ending March 31, 2026, with 9.42% growth. This brings the company's revenue in the last twelve months to $10.63B, up 7.14% year-over-year. In the year 2025, Alcon had annual revenue of $10.40B with 4.94% growth.
Revenue (ttm)
$10.63B
Revenue Growth
+7.14%
P/S Ratio
3.11
Revenue / Employee
$425.36K
Employees
25,000
Market Cap
26.55B CHF
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.40B | 490.00M | 4.94% |
| Dec 31, 2024 | 9.91B | 456.00M | 4.82% |
| Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
| Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
| Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
| Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
| Dec 31, 2019 | 7.51B | 355.00M | 4.96% |
| Dec 31, 2018 | 7.15B | 361.00M | 5.32% |
| Dec 31, 2017 | 6.79B | 200.00M | 3.03% |
| Dec 31, 2016 | 6.59B | -161.00M | -2.38% |
| Dec 31, 2015 | 6.75B | -426.00M | -5.93% |
| Dec 31, 2010 | 7.18B | 680.00M | 10.46% |
| Dec 31, 2009 | 6.50B | 205.00M | 3.26% |
| Dec 31, 2008 | 6.29B | 695.00M | 12.41% |
| Dec 31, 2007 | 5.60B | 702.40M | 14.34% |
| Dec 31, 2006 | 4.90B | 528.10M | 12.09% |
| Dec 31, 2005 | 4.37B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 45.38B |
| Sandoz Group AG | 8.85B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Galenica AG | 4.15B |
| Sonova Holding AG | 3.61B |
| Straumann Holding AG | 2.61B |
Alcon News
- 2 days ago - RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook - MarketBeat
- 5 days ago - RxSight Updates FY2026 Revenue Outlook After Alcon Deal; Cuts Product Sales Forecast; Stock Down - Nasdaq
- 5 days ago - Alcon Inks Partnership With RxSight To Develop Adjustable PICOLs For Deal Value Up To $200 Mln - Nasdaq
- 6 days ago - Mexican Gold Mining Corp.: Alcon Silver Announces Shareholder Approval of Arrangement - Finanz Nachrichten
- 6 days ago - Alcon Silver Announces Shareholder Approval of Arrangement - Wallstreet:Online
- 6 days ago - Alcon (ALC) Partners with RxSight for Innovative Lens Development - GuruFocus
- 6 days ago - Alcon, RxSight enter non-exclusive pact to develop adjustable PCIOLs - TheFly
- 6 days ago - Alcon, RxSight announce collaboration to develop adjustable PCIOLs - TheFly